NCT03282981View on ClinicalTrials.gov

Beta Adrenergic Antagonist for the Healing of Chronic DFU

PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 24, 2018

Primary Completion Date

December 1, 2023

Study Completion Date

April 30, 2024

Conditions
Chronic Diabetic Foot UlcersDiabetic Neuropathic UlcersNon Healing Wound
Interventions
DRUG

Timolol

Topical application of Timolol on non-healing diabetic foot ulcers

DRUG

Non biologically active gel

Topical application of non biologically active gel (Hydrogel- standard of care) on non-healing diabetic foot ulcers

Trial Locations (1)

95655-4200

VA Northern California Health Care System, Mather, CA, Sacramento

All Listed Sponsors
collaborator

VA Northern California Health Care System

FED

lead

VA Office of Research and Development

FED

NCT03282981 - Beta Adrenergic Antagonist for the Healing of Chronic DFU | Biotech Hunter | Biotech Hunter